Skip to main content
Clinical Trials/CTRI/2021/12/038901
CTRI/2021/12/038901Not yet recruitingPhase 2

A clinical trial to evaluate the efficacy of oral administration of Clitoria ternatea Linn. powder and Saraswata Ghrita Nasya in the management of Autism Spectrum Disorder in paediatric population. - Autism spectrum disorder, Saraswata Ghrita, Nasya, Ayurveda

All India Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Children between 2-12 years of age, either of gender, fulfilling the screening criteria of Autism Spectrum Disorder and Parents/Guardian are willing to give informed written consent to participate, will be included in the study.

Exclusion Criteria

  • Children with chronic systemic illnesses or taking anti-epileptic or anti-psychotic drugs or Parents/Guardian not willing to give informed written consent to participate, will be excluded from the study.

Investigators

Similar Trials